These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 10955925

  • 21. Renal biopsy in children with steroid-dependent nephrotic syndrome.
    Skalova S, Podhola M, Geier P, Tichy T.
    Bratisl Lek Listy; 2009; 110(10):647-9. PubMed ID: 20017458
    [Abstract] [Full Text] [Related]

  • 22. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 23. Minimal-lesion nephrotic syndrome with early resistance to steroid therapy.
    Siegel NJ, Gur A, Krassner LS, Kashgarian M.
    J Pediatr; 1975 Sep; 87(3):377-80. PubMed ID: 1165516
    [Abstract] [Full Text] [Related]

  • 24. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 25. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R, Brem AS.
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [Abstract] [Full Text] [Related]

  • 26. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    N Engl J Med; 1982 Feb 25; 306(8):451-4. PubMed ID: 7035953
    [Abstract] [Full Text] [Related]

  • 27. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr 25; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 28. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome.
    Bircan Z, Kara B.
    Pediatr Int; 2003 Feb 25; 45(1):65-7. PubMed ID: 12654072
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
    Moudgil A, Bagga A, Jordan SC.
    Pediatr Nephrol; 2005 Oct 25; 20(10):1376-81. PubMed ID: 15977023
    [Abstract] [Full Text] [Related]

  • 30. Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment.
    Siegel NJ, Gaudio KM, Krassner LS, McDonald BM, Anderson FP, Kashgarian M.
    Kidney Int; 1981 Mar 25; 19(3):454-9. PubMed ID: 7241883
    [Abstract] [Full Text] [Related]

  • 31. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H, Jaureguiberry G, Dufek S, Tullus K, Bockenhauer D.
    Pediatr Nephrol; 2016 Apr 25; 31(4):589-94. PubMed ID: 26525199
    [Abstract] [Full Text] [Related]

  • 32. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
    Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
    [Abstract] [Full Text] [Related]

  • 33. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.
    Garin EH, Pryor ND, Fennell RS, Richard GA.
    J Pediatr; 1978 Feb 27; 92(2):304-8. PubMed ID: 621614
    [Abstract] [Full Text] [Related]

  • 34. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U, Kranz B, Zimmermann S, Hoyer PF.
    Pediatr Nephrol; 2003 Jul 27; 18(7):661-4. PubMed ID: 12750975
    [Abstract] [Full Text] [Related]

  • 35. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N, Topaloglu R, Saatci O, Bakkaloglu A.
    Clin Pediatr (Phila); 1992 May 27; 31(5):283-8. PubMed ID: 1582094
    [Abstract] [Full Text] [Related]

  • 36. Late nonresponsiveness to steroids in children with the nephrotic syndrome.
    Trainin EB, Boichis H, Spitzer A, Edelmann CM, Greifer I.
    J Pediatr; 1975 Oct 27; 87(4):519-23. PubMed ID: 1159578
    [Abstract] [Full Text] [Related]

  • 37. Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome.
    Wingen AM, Müller-Wiefel DE, Schärer K.
    Clin Nephrol; 1985 Jan 27; 23(1):35-40. PubMed ID: 3978880
    [Abstract] [Full Text] [Related]

  • 38. Childhood nephrotic syndrome: clinical associations and response to therapy.
    Grupe WE.
    Postgrad Med; 1979 May 27; 65(5):229-31, 234-6. PubMed ID: 432155
    [Abstract] [Full Text] [Related]

  • 39. Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome.
    Ito S, Ikeda H, Harada T, Kamei K, Takahashi E.
    Pediatr Nephrol; 2011 Oct 27; 26(10):1921-2. PubMed ID: 21710249
    [No Abstract] [Full Text] [Related]

  • 40. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.